VEGFA and myopia: Although major clinical trials have identified that myopia prevalence is low in eyes treated with anti-VEGF compared to LPC (<5%), there are numerous studies and systematic reviews that state that children receiving anti-VEGF therapy can still develop myopia and even high myopia.